ImmuVen's Unattributed Round

ImmuVen raised a round of funding on August 15, 2011.

ImmuVen develops drugs that can be used to treat infectious diseases and cancer. The company features life science technology, T cell receptors, a unique class of immune-targeting therapeutic and diag…

Articles about ImmuVen's Unattributed Round: